Literature DB >> 35041131

Stereopsis after corneal refractive surgeries: a systematic review and meta-analysis.

Alireza Peyman1, Mohsen Pourazizi1, Mohamadreza Akhlaghi1, Awat Feizi2, Alireza Rahimi3, Elham Soltani4.   

Abstract

PURPOSE: To systematically review the published manuscripts on stereopsis after corneal refractive surgery.
METHODS: The Web of Science, PubMed, Scopus, ProQuest, Clinical Key, Embase, and Cochrane Library were searched for relevant articles published until August 2020. The fixed- or random-effects models were used to estimate the Weighted mean difference (WMD) or Relative risk (RR) and 95% Confidence interval (CI) for postoperative stereopsis changes and incidence when applicable. Meta-regression was conducted for adjusting the effects of potential confounders.
RESULTS: Seven studies (1266 eyes) in adults and ten studies in pediatrics (259 eyes) were included. In adults, stereopsis improved significantly compared to the preoperative state (WMD = - 27.4, 95% CI = - 40.0, - 14.7; I2 = 97.8%; P < 0.001). In pediatrics, proportion of patients with stereoacuity postoperatively was 2.18 times compared to preoperative evaluation. (RR = 2.18, 95% CI = 1.2, 3.9; I2 = 68.6%, P < 0.001).
CONCLUSIONS: Stereopsis improves after corneal refractive surgery in adults and pediatrics.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Corneal surgery; Refractive surgery; Stereoacuity; Stereopsis

Mesh:

Year:  2022        PMID: 35041131     DOI: 10.1007/s10792-021-02201-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  41 in total

Review 1.  Corneal refractive surgery: past to present.

Authors:  Colm McAlinden
Journal:  Clin Exp Optom       Date:  2012-06-07       Impact factor: 2.742

2.  Prevalence of laser vision correction in ophthalmologists who perform refractive surgery.

Authors:  Guy M Kezirian; Gregory D Parkhurst; Jason P Brinton; Richard A Norden
Journal:  J Cataract Refract Surg       Date:  2015-09       Impact factor: 3.351

Review 3.  Binocular vision alterations after refractive and cataract surgery: a review.

Authors:  María García-Montero; César Albarrán Diego; Nuria Garzón-Jiménez; Rafael J Pérez-Cambrodí; Esther López-Artero; Juan Carlos Ondategui-Parra
Journal:  Acta Ophthalmol       Date:  2018-09-14       Impact factor: 3.761

4.  Impact of intraocular scatter on stereopsis.

Authors:  Jun-Lei Zhao; Fei Xiao; Hao-Xin Zhao; Yun Dai; Yu-Dong Zhang
Journal:  Vision Res       Date:  2018-08-30       Impact factor: 1.886

5.  Influence of stereopsis on the ability to perform simulated microsurgery.

Authors:  James Dutton; Alice Watkins; Jack Henderson; Frederick R Burgess; Naing L Tint; Baljean Dhillon; Andrew J Tatham
Journal:  J Cataract Refract Surg       Date:  2020-04       Impact factor: 3.351

6.  The Critical Role of Stereopsis in Virtual and Mixed Reality Learning Environments.

Authors:  Bruce Wainman; Giancarlo Pukas; Liliana Wolak; Sylvia Mohanraj; Jason Lamb; Geoffrey R Norman
Journal:  Anat Sci Educ       Date:  2019-11-20       Impact factor: 5.958

Review 7.  LASIK complications: etiology, management, and prevention.

Authors:  S A Melki; D T Azar
Journal:  Surv Ophthalmol       Date:  2001 Sep-Oct       Impact factor: 6.048

Review 8.  Visual outcomes and management after corneal refractive surgery: A review.

Authors:  Ane Murueta-Goyena; Pilar Cañadas
Journal:  J Optom       Date:  2017-11-26

9.  A Comparison of Visual Outcomes and Patient Satisfaction Between Photorefractive Keratectomy and Femtosecond Laser-Assisted In Situ Keratomileusis.

Authors:  Nauman Hashmani; Sharif Hashmani; Priyanka Ramesh; Hina Rajani; Junaid Ahmed; Jaish Kumar; Arun Kumar; Munira Jamali
Journal:  Cureus       Date:  2017-09-01

10.  Patients' satisfaction and subjective happiness after refractive surgery for myopia.

Authors:  Shinichiro Matsuguma; Kazuno Negishi; Motoko Kawashima; Ikuko Toda; Masahiko Ayaki; Kazuo Tsubota
Journal:  Patient Prefer Adherence       Date:  2018-09-25       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.